跳至主要内容
临床试验/NCT06556433
NCT06556433招募中不适用

Alaska Native Family-Based, Financial Incentives Intervention for Smoking Cessation: An RCT

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 1,312 人开始时间: 2024年9月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Mayo Clinic
入组人数
1,312
试验地点
1
主要终点
Change in smoking status

研究概览

简要总结

The current study will conduct an RCT to evaluate the effectiveness of a family-based incentive intervention with Alaska Native/American Indian families. The experimental arm will be compared to a control arm on biochemically-confirmed smoking abstinence at 6- and 12-months post-intervention.

详细描述

Dyads will be stratified by the index participant's sex, and residence with family member, and by the family member's current smoking status then randomized to a no incentives control condition (n=328 dyads) or a 6-month incentive intervention (n=328 dyads).

All dyads will receive existing evidence-based cessation materials on treatment resources and social support strategies. The study will measure the index participant's smoking status in both study groups weekly during the first four weeks, and at three and six months. All participants, including support persons, will receive incentives when they complete each of the smoking status assessments. The intervention group will additionally receive individual rewards provided to the index participant for achieving verified smoking abstinence at each time point, to a maximum of $750.

The enrolled family member will also receive rewards equivalent to the value earned by the index participant that can contribute to family needs. The study will explore potential moderators (e.g., family member smoking status, index participant's sex) and mediators (e.g., interdependence) of intervention effects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Index Participant Inclusion Criteria:
  • •Alaska Native/American Indian (ANAI) person (based on self-reported race) and reside in Alaska.
  • •Age ≥18 years.
  • •Self-report smoking in the past 7 days, biochemically verified with saliva cotinine ≥ 30 ng/mL (positive result based on at-home saliva swab test provided by study team).
  • •Smoked ≥ 3 cigarettes per day over the past 3 months.
  • •Considering or willing to make a quit attempt.
  • •Have or will nominate one adult family member to enroll with them.
  • •Own or have access to a mobile phone or tablet with Internet and text messaging capabilities, or will be loaned an iPad for the study duration
  • •Willing to upload photos of self during completion of smoking status tests.
  • •Willing to complete and sign an Internal Revenue Service (IRS) W-9 tax identification form if they wish to receive payments on the study.
  • •Willing to provide written informed consent and participate in study-related tests and procedures.
  • •Index Participant

排除标准

  • •Already enrolled in the study with another family member.
  • •Participated in a prior study phase.
  • •Family Member Participant Inclusion Criteria (regardless of smoking status or residence with the index participant):
  • •Age ≥18 years.
  • •Defined as family and nominated by the index participant, or have an ANAI family member who is ≥18 years and smokes that they would like to support in quitting.
  • •Own or have access to a mobile phone or tablet with Internet and text messaging capabilities, or will be loaned an iPad for the study duration.
  • •Willing to complete and sign an IRS W-9 tax identification form if they wish to receive payments on the study.
  • •Willing to provide written informed consent and participate in study related tests and procedures.
  • •Both men and women, those from non-ANAI racial/ethnic groups, and those who live outside of Alaska in the United States will be eligible family member participants.
  • •Family Member Participant Exclusion Criteria:
  • •Already enrolled with another family member.
  • •Participated in a prior study phase.
  • •After the randomized controlled trial, qualitative interviews will be conducted with index participants, family member participants, and Alaska Tribal Health System Stakeholders to inform program implementation. Healthcare providers, cessation specialists, Elder advisors, and Tribal Health System leaders and stakeholders will be invited by the Alaska Native Tribal Health Consortium team and separately consented and interviewed.

研究组 & 干预措施

Comparison Group

No Intervention

Index participants in the Comparison Group will be scheduled to complete smoking status check-ins six times during the 6-month Treatment Phase: weekly for four weeks, then at three and six months. At each check-in, cigarette smoking abstinence will be assessed. Participants in the Comparison Group will receive informational materials on smoking cessation.

Rewards Group

Experimental

Index participants in the Rewards Group will be scheduled to complete smoking status check-ins six times during the 6-month Treatment Phase: weekly for four weeks, then at three and six months. At each check-in, cigarette smoking abstinence will be assessed. Participants in the Rewards Group will receive informational materials on smoking cessation.

干预措施: Financial Incentive Rewards (Behavioral)

结局指标

主要结局

Change in smoking status

时间窗: 6 months, 12 months

Number of participants to have biochemically verified, prolonged smoking abstinence.

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Christi Patten

Director, Behavioral Health Research Program

Mayo Clinic

研究点 (1)

Loading locations...

相似试验